CaroGen
Kartik Natarajan is currently the Senior Director of Diversified Alternative Equity at Barings. Kartik also serves as an Advisor to the Founder at Peritia Capital Management and Advisor to the Chief Executive Officer at CaroGen Corporation. Previously, Kartik held roles such as Head Of Investor Relations at Blue Cloud Ventures, Managing Director at Madison Park Group, and Co-Founder at Elm City Ventures. Kartik's educational background includes a Master of Business Administration in Finance from the Yale School of Management, a Master's degree in Biochemistry and Molecular Biology from the University of Connecticut, and a MSc (Hons) in Biological Science from Birla Institute of Technology and Science, Pilani.
This person is not in any teams
This person is not in any offices
CaroGen
1 followers
CaroGen Corporation is an emerging biopharmaceutical company with an entirely new vaccine platform technology developed at Yale University School of Medicine.